Skip to content
healthcare.dev

cevimeline hydrochloride

NDC 40032-999, cevimeline hydrochloride, capsule, from Novel Laboratories, Inc..

Product NDC
40032-999
Status
Listed
Labeler
Novel Laboratories, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204746
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/40032-999 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
40032-999-0140032099901100 CAPSULE in 1 BOTTLE (40032-999-01)
40032-999-034003209990330 CAPSULE in 1 BOTTLE (40032-999-03)
40032-999-0540032099905500 CAPSULE in 1 BOTTLE (40032-999-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7432a48-1142-431e-997f-8419dc724824

Use it

Look up 40032-999 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/40032-999 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 40032-999. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.